Stephens & Co. Maintains Overweight on AvePoint, Raises Price Target to $17
Stephens & Co. analyst Todd Weller maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $16 to $17.
Stocks · News reference
AvePoint Lowers FY2026 Sales Guidance from $509.400M-$517.400M to $508.500M-$512.500M vs $512.730M Est
AvePoint (NASDAQ:AVPT) lowers FY2026 sales outlook from $509.400 million-$517.400 million to $508.500 million-$512.500 million vs $512.730 million estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of software companies are trading higher after AI executives from firms including Anthropic, OpenAI and SpaceXAI signaled that the industry's growth may have to be slowed, which may limit threats to software vendors.
Scotiabank Maintains Sector Outperform on AvePoint, Raises Price Target to $15
Scotiabank analyst Joe Vandrick maintains AvePoint (NASDAQ:AVPT) with a Sector Outperform and raises the price target from $12 to $15.
TD Cowen Maintains Buy on AvePoint, Raises Price Target to $15
TD Cowen analyst Derrick Wood maintains AvePoint (NASDAQ:AVPT) with a Buy and raises the price target from $14 to $15.